Successfully climbing the "sTAIRs": Surmounting failed translation of experimental ischemic stroke treatments

Stroke Research and Treatment

Volumn , Issue , 2012, Pages

  Kahle, Michael P ^a,b   Bix, Gregory J ^b  

^a TEXAS A M COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CLIMBING; COMORBIDITY; DISEASE DURATION; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; HUMAN; NONHUMAN; POLYPHARMACY; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; SAMPLE SIZE; TREATMENT OUTCOME;

EID: 84872759925     PISSN: None     EISSN: 20420056     Source Type: Journal    
DOI: 10.1155/2012/374098     Document Type: Review

References (35)

1. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics-2012 update: a report from the american heart association. Circulation 2012 125 1 e2 e220
2. Chaudhary N., Pandey A. S., Gemmete J. J., Intervention in acute cerebral ischaemic stroke: a review of the role of pharmacological therapies and intra-arterial mechanical thrombectomy devices. Postgraduate Medical Journal 2011 87 1032 714 723
3. Maiser S. J., Georgiadis A. L., Suri M. F. K., Vazquez G., Lakshminarayan K., Qureshi A. I., Intravenous recombinant tissue plasminogen activator administered after 3 h following onset of ischaemic stroke: a metaanalysis. International Journal of Stroke 2011 6 1 25 32 2-s2.0-78650970741 10.1111/j.1747-4949.2010.00537.x
4. Fisher M., Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999 30 12 2752 2758 2-s2.0-0344065373
5. Fisher M., Feuerstein G., Howells D. W., Hurn P. D., Kent T. A., Savitz S. I., Lo E. H., Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009 40 6 2244 2250 2-s2.0-66849097996 10.1161/STROKEAHA.108.541128
6. Philip M., Benatar M., Fisher M., Savitz S. I., Methodological quality of animal studies of neuroprotective agents currently in phase II/III acute ischemic stroke trials. Stroke 2009 40 2 577 581 2-s2.0-60549107281 10.1161/STROKEAHA.108.524330
7. Horie N., Maag A. L., Hamilton S. A., Shichinohe H., Bliss T. M., Steinberg G. K., Mouse model of focal cerebral ischemia using endothelin-1. Journal of Neuroscience Methods 2008 173 2 286 290 2-s2.0-48049096808 10.1016/j.jneumeth.2008.06.013
8. Belayev L., Lapchak P. A., Zhang J. H., Overcoming barriers to translation from experimental stroke models. Translational Stroke Research 2012 3 chapter 24 Springer 471 492
9. Maeda K., Hata R., Hossmann K. A., Differences in the cerebrovascular anatomy of C57Black/6 and SV129 mice. NeuroReport 1998 9 7 1317 1319 2-s2.0-0032507585 (Pubitemid 28264243)
10. Kelly S., McCulloch J., Horsburgh K., Minimal ischaemic neuronal damage and HSP70 expression in MF1 strain mice following bilateral common carotid artery occlusion. Brain Research 2001 914 1-2 185 195 2-s2.0-0035964850 10.1016/S0006-8993(01)02801-3 (Pubitemid 32905445)
11. Willing A. E., Experimental models: help or hindrance. Stroke 2009 40 3 S152 S154 2-s2.0-62949244066 10.1161/STROKEAHA.108.533505
12. McColl B. W., Carswell H. V., McCulloch J., Horsburgh K., Extension of cerebral hypoperfusion and ischaemic pathology beyond MCA territory after intraluminal filament occlusion in C57Bl/6J mice. Brain Research 2004 997 1 15 23 2-s2.0-1642319646
13. Cook D. J., Tymianski M., Nonhuman primate models of stroke for translational neuroprotection research. Neurotherapeutics 2012 9 2 371 379
14. Ankolekar S., Rewell S., Howells D. W., Bath P. M., The influence of stroke risk factors and comorbidities on assessment of stroke therapies in humans and animals. International Journal of Stroke 2012 7 5 386 397
15. Wiszniewska M., Niewada M., Czlonkowska A., Sex differences in risk factor distribution, severity, and outcome of ischemic stroke. Acta Clinica Croatica 2011 50 1 21 28
16. Liu M., Dziennis S., Hurn P. D., Alkayed N. J., Mechanisms of gender-linked ischemic brain injury. Restorative Neurology and Neuroscience 2009 27 3 163 179 2-s2.0-68149168835 10.3233/RNN-2009-0467
17. Roger V. L., Go A. S., Lloyd-Jones D. M., Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 4 e18 e209
18. Macrae I. M., Preclinical stroke research-advantages and disadvantages of the most common rodent models of focal ischaemia. British Journal of Pharmacology 2011 164 4 1062 1078
19. Guluma K., Lapchak P. A., Zhang J. H., Clinical relevance in a translational rodent model of acute ischemic stroke: incorporating the biological variability of spontaneous recanalization. Translational Stroke Research 2012 3 chapter 26 Springer 525 540
20. Hossmann K. A., Cerebral ischemia: models, methods and outcomes. Neuropharmacology 2008 55 3 257 270 2-s2.0-48849093738 10.1016/j.neuropharm. 2007.12.004
21. Hossmann K. A., The two pathophysiologies of focal brain ischemia: implications for translational stroke research. Journal of Cerebral Blood Flow and Metabolism 2012 32 7 1310 1316
22. Carmichael S. T., Rodent models of focal stroke: size, mechanism, and purpose. NeuroRx 2005 2 3 396 409 2-s2.0-26844435654 10.1602/neurorx.2.3.396 (Pubitemid 41444874)
23. Doyle K. P., Fathali N., Siddiqui M. R., Buckwalter M. S., Distal hypoxic stroke: a new mouse model of stroke with high throughput, low variability and a quantifiable functional deficit. Journal of Neuroscience Methods 2012 207 1 31 40
24. Liu S., Zhen G., Meloni B. P., Campbell K., Winn H. R., Rodent stroke model guidelines for preclinical stroke trials (1st Edition). Journal of Experimental Stroke & Translational Medicine 2009 2 2 2 27
25. Sakai H., Sheng H., Yates R. B., Ishida K., Pearlstein R. D., Warner D. S., Isoflurane provides long-term protection against focal cerebral ischemia in the rat. Anesthesiology 2007 106 1 92 99 2-s2.0-33845949949 10.1097/00000542- 200701000-00017 (Pubitemid 46035408)
26. Mei L. C., Yang J., Kem S., Klaidman L., Sugawara T., Chan P. H., Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion. Neuroscience Letters 2002 322 3 137 140 2-s2.0-0037066384 (Pubitemid 34230538)
27. Zhang Y. L., Zhang P. B., Qiu S. D., Liu Y., Tian Y. F., Wang Y., Effects of ketamine-midazolam anesthesia on the expression of NMDA and AMPA receptor subunit in the peri-infarction of rat brain. Chinese Medical Journal 2006 119 18 1555 1562 2-s2.0-33749059935 (Pubitemid 44462926)
28. Proescholdt M., Heimann A., Kempski O., Neuroprotection of S(+) ketamine isomer in global forebrain ischemia. Brain Research 2001 904 2 245 251 2-s2.0-0035933557 10.1016/S0006-8993(01)02465-9 (Pubitemid 32537648)
29. Stankowski J. N., Gupta R., Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxidants and Redox Signaling 2011 14 10 1841 1851 2-s2.0-79954571076 10.1089/ars.2010.3292
30. Turner R. J., Jickling G. C., Sharp F. R., Are underlying assumptions of current animal models of human stroke correct: from STAIRs to high hurdles? Translational Stroke Research 2011 2 2 138 143 2-s2.0-79955725794 10.1007/s12975-011-0067-3
31. Singhal A. B., Lo E. H., Dalkara T., Moskowitz M., Gonzalez R. G., Ischemic stroke: basic pathophysiology and neuroprotective strategies. Acute Ischemic Stroke 2011 chapter 1 Berlin, Germany Springer 1 24
32. Sutherland B. A., Minnerup J., Balami J. S., Neuroprotection for ischaemic stroke: translation from the bench to the bedside. International Journal of Stroke 2012 7 5 407 418
33. Manawadu B. S. D., Jarosz J., Kalra L., Abstract 56: thrombolysis in selected patients with wake up stroke is feasible with similar safety as thrombolysis in 0-4.5 hours. Stroke 2012 43 A56
34. Vesterinen H. V., Egan K., Deister A., Schlattmann P., MacLeod M. R., Dirnagl U., Systematic survey of the design, statistical analysis, and reporting of studies. Journal of Cerebral Blood Flow and Metabolism 2011 31 4 1064 1072 2-s2.0-79953292900 10.1038/jcbfm.2010.217
35. Liu F., Schafer D. P., McCullough L. D., TTC, Fluoro-Jade B and NeuN staining confirm evolving phases of infarction induced by middle cerebral artery occlusion. Journal of Neuroscience Methods 2009 179 1 1 8 2-s2.0-61649086903 10.1016/j.jneumeth.2008.12.028